-
Je něco špatně v tomto záznamu ?
Precision nutrition in pediatric IBD: A position paper from the ESPGHAN special interest group for basic science and translational research, the IBD Porto group, and allied health professionals
K. Gerasimidis, RK. Russell, F. Giachero, K. Gkikas, B. Tel, A. Assa, J. Bronsky, L. de Ridder, I. Hojsak, A. Jenke, L. Norsa, R. Sigall-Boneh, S. Sila, E. Wine, M. Zilbauer, C. Strisciuglio, M. Gasparetto, ESPGHAN Special Interest Group in Basic...
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
Grantová podpora
None
PubMed
38374554
DOI
10.1002/jpn3.12096
Knihovny.cz E-zdroje
- MeSH
- Crohnova nemoc * terapie MeSH
- dítě MeSH
- idiopatické střevní záněty * terapie MeSH
- indukce remise MeSH
- lidé MeSH
- pomocný zdravotnický personál MeSH
- translační biomedicínský výzkum MeSH
- veřejné mínění MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Stratified and precision nutrition refers to disease management or prevention of disease onset, based on dietary interventions tailored to a person's characteristics, biology, gut microbiome, and environmental exposures. Such treatment models may lead to more effective management of inflammatory bowel disease (IBD) and reduce risk of disease development. This societal position paper aimed to report advances made in stratified and precision nutritional therapy in IBD. Following a structured literature search, limited to human studies, we identified four relevant themes: (a) nutritional epidemiology for risk prediction of IBD development, (b) food-based dietary interventions in IBD, (c) exclusive enteral nutrition (EEN) for Crohn's disease (CD) management, and (d) pre- and probiotics for IBD management. There is scarce literature upon which we can make recommendations for precision or stratified dietary therapy for IBD, both for risk of disease development and disease management. Certain single-nucleotide polymorphisms related to polyunsaturated fatty acid (PUFA) metabolism may modify the effect dietary PUFA have in increasing the risk of IBD development. Non-colonic CD, mild-to-moderate CD, and high microbiota richness may predict success of EEN and may be used both for prediction of treatment continuation, but also for early cessation in nonresponders. There is currently insufficient evidence to make recommendations for precision or stratified dietary therapy for patients with established IBD. Despite the great interest in stratified and precision nutrition, we currently lack data to support conclusive recommendations. Replication of early findings by independent research groups and within structured clinical interventions is required.
Amsterdam University Medical Centers Amsterdam The Netherlands
Children's Hospital Kassel University of Witten Herdecke Witten Germany
Children's Hospital Zagreb University of Zagreb Medical School Zagreb Croatia
Department of Human Nutrition School of Medicine University of Glasgow Glasgow UK
Department of Paediatrics University Hospital Motol Prague Czech Republic
Israel Pediatric Gastroenterology and Nutrition Unit The E Wolfson Medical Center Holon Israel
Norwich Medical School Faculty of Medicine and Health Science University of East Anglia Norwich UK
Pediatric Center MTA Center of Excellence Semmelweis University Budapest Hungary
Pediatric Hepatology Gastroenterology and Transplantation ASST Papa Giovanni XXIII Bergamo Italy
Sophia Children's Hospital Erasmus MC University Rotterdam The Netherlands
Wellcome MRC Stem Cell Institute University of Cambridge Cambridge UK
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24007232
- 003
- CZ-PrNML
- 005
- 20240423155818.0
- 007
- ta
- 008
- 240412s2024 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/jpn3.12096 $2 doi
- 035 __
- $a (PubMed)38374554
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Gerasimidis, Konstantinos $u Department of Human Nutrition, School of Medicine, University of Glasgow, Glasgow, UK
- 245 10
- $a Precision nutrition in pediatric IBD: A position paper from the ESPGHAN special interest group for basic science and translational research, the IBD Porto group, and allied health professionals / $c K. Gerasimidis, RK. Russell, F. Giachero, K. Gkikas, B. Tel, A. Assa, J. Bronsky, L. de Ridder, I. Hojsak, A. Jenke, L. Norsa, R. Sigall-Boneh, S. Sila, E. Wine, M. Zilbauer, C. Strisciuglio, M. Gasparetto, ESPGHAN Special Interest Group in Basic and Translational Research; the ESPGHAN IBD Porto Working Group; the ESPGHAN Allied Health Professionals
- 520 9_
- $a Stratified and precision nutrition refers to disease management or prevention of disease onset, based on dietary interventions tailored to a person's characteristics, biology, gut microbiome, and environmental exposures. Such treatment models may lead to more effective management of inflammatory bowel disease (IBD) and reduce risk of disease development. This societal position paper aimed to report advances made in stratified and precision nutritional therapy in IBD. Following a structured literature search, limited to human studies, we identified four relevant themes: (a) nutritional epidemiology for risk prediction of IBD development, (b) food-based dietary interventions in IBD, (c) exclusive enteral nutrition (EEN) for Crohn's disease (CD) management, and (d) pre- and probiotics for IBD management. There is scarce literature upon which we can make recommendations for precision or stratified dietary therapy for IBD, both for risk of disease development and disease management. Certain single-nucleotide polymorphisms related to polyunsaturated fatty acid (PUFA) metabolism may modify the effect dietary PUFA have in increasing the risk of IBD development. Non-colonic CD, mild-to-moderate CD, and high microbiota richness may predict success of EEN and may be used both for prediction of treatment continuation, but also for early cessation in nonresponders. There is currently insufficient evidence to make recommendations for precision or stratified dietary therapy for patients with established IBD. Despite the great interest in stratified and precision nutrition, we currently lack data to support conclusive recommendations. Replication of early findings by independent research groups and within structured clinical interventions is required.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a translační biomedicínský výzkum $7 D057170
- 650 _2
- $a veřejné mínění $7 D011639
- 650 12
- $a idiopatické střevní záněty $x terapie $7 D015212
- 650 12
- $a Crohnova nemoc $x terapie $7 D003424
- 650 _2
- $a indukce remise $7 D012074
- 650 _2
- $a pomocný zdravotnický personál $7 D000488
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Russell, Richard K $u Department of Paediatric Gastroenterology, Hepatology and Nutrition, Royal Hospital for Children and Young People, Edinburgh, UK
- 700 1_
- $a Giachero, Federica $u Department of Paediatric Gastroenterology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Trust, Cambridge, UK
- 700 1_
- $a Gkikas, Konstantinos $u Department of Human Nutrition, School of Medicine, University of Glasgow, Glasgow, UK
- 700 1_
- $a Tel, Balint $u Pediatric Center, MTA Center of Excellence, Semmelweis University, Budapest, Hungary
- 700 1_
- $a Assa, Amit $u The Juliet Keidan Institute of Pediatric Gastroenterology Hepatology and Nutrition, Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel
- 700 1_
- $a Bronsky, Jiri $u Department of Paediatrics, University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a de Ridder, Lissy $u Sophia Children's Hospital, Erasmus MC University, Rotterdam, The Netherlands
- 700 1_
- $a Hojsak, Iva $u Children's Hospital Zagreb, University of Zagreb Medical School, Zagreb, Croatia
- 700 1_
- $a Jenke, Andreas $u Children's Hospital Kassel, University of Witten/Herdecke, Witten, Germany
- 700 1_
- $a Norsa, Lorenzo $u Pediatric Hepatology, Gastroenterology and Transplantation ASST Papa Giovanni XXIII, Bergamo, Italy
- 700 1_
- $a Sigall-Boneh, Rotem $u Israel Pediatric Gastroenterology and Nutrition Unit, The E. Wolfson Medical Center, Holon, Israel $u Amsterdam University Medical Centers, Amsterdam, The Netherlands
- 700 1_
- $a Sila, Sara $u Referral Center for Pediatric Gastroenterology and Nutrition, Children's Hospital Zagreb, Zagreb, Croatia
- 700 1_
- $a Wine, Eytan $u Department of Pediatrics, Division of Pediatric Gastroenterology, University of Alberta, Edmonton, Alberta, Canada
- 700 1_
- $a Zilbauer, Matthias $u Wellcome MRC Stem Cell Institute, University of Cambridge, Cambridge, UK
- 700 1_
- $a Strisciuglio, Caterina $u Department of Woman, Child and General and Specialist Surgery, University of Campania "Vanvitelli", Napoli, Italy
- 700 1_
- $a Gasparetto, Marco $u Department of Paediatric Gastroenterology, Jenny Lind Children's Hospital, Norfolk and Norwich University Hospitals, Norwich, UK $u Norwich Medical School, Faculty of Medicine and Health Science, University of East Anglia (UEA), Norwich, UK
- 710 2_
- $a ESPGHAN Special Interest Group in Basic and Translational Research; the ESPGHAN IBD Porto Working Group; the ESPGHAN Allied Health Professionals
- 773 0_
- $w MED00010080 $t Journal of pediatric gastroenterology and nutrition $x 1536-4801 $g Roč. 78, č. 2 (2024), s. 428-445
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38374554 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20240423155815 $b ABA008
- 999 __
- $a ok $b bmc $g 2081302 $s 1216999
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 78 $c 2 $d 428-445 $e 20231227 $i 1536-4801 $m Journal of pediatric gastroenterology and nutrition $n J Pediatr Gastroenterol Nutr $x MED00010080
- GRA __
- $p None
- LZP __
- $a Pubmed-20240412
